Press Releases Year None20232022202120202019201820172015 June 2, 2023 ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) May 31, 2023 ORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference May 8, 2023 ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates May 5, 2023 ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) April 25, 2023 ORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Investor Conference April 18, 2023 ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting March 16, 2023 ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates March 14, 2023 ORIC Pharmaceuticals Announces Multiple Presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting March 6, 2023 ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare Conference February 3, 2023 ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 13